nodes	percent_of_prediction	percent_of_DWPC	metapath
Duloxetine—SLC6A4—panic disorder	0.448	0.566	CbGaD
Duloxetine—HTR2A—panic disorder	0.344	0.435	CbGaD
Duloxetine—SLC6A2—locus ceruleus—panic disorder	0.0113	0.166	CbGeAlD
Duloxetine—SLC6A2—sympathetic nervous system—panic disorder	0.00893	0.131	CbGeAlD
Duloxetine—HTR2A—locus ceruleus—panic disorder	0.00679	0.0996	CbGeAlD
Duloxetine—SLC6A2—autonomic nervous system—panic disorder	0.006	0.088	CbGeAlD
Duloxetine—HTR2A—sympathetic nervous system—panic disorder	0.00537	0.0787	CbGeAlD
Duloxetine—HTR2A—vagus nerve—panic disorder	0.0052	0.0762	CbGeAlD
Duloxetine—HTR2A—autonomic nervous system—panic disorder	0.00361	0.0529	CbGeAlD
Duloxetine—HTR2A—peripheral nervous system—panic disorder	0.0026	0.0382	CbGeAlD
Duloxetine—SLC6A3—brainstem—panic disorder	0.0018	0.0264	CbGeAlD
Duloxetine—HTR2C—brainstem—panic disorder	0.00174	0.0255	CbGeAlD
Duloxetine—NPY1R—brain—panic disorder	0.00171	0.0251	CbGeAlD
Duloxetine—Naphazoline—ADRA2A—panic disorder	0.00168	0.295	CrCbGaD
Duloxetine—SLC6A4—brainstem—panic disorder	0.00165	0.0241	CbGeAlD
Duloxetine—SLC6A2—brainstem—panic disorder	0.00145	0.0213	CbGeAlD
Duloxetine—HTR6—brain—panic disorder	0.0012	0.0177	CbGeAlD
Duloxetine—Protriptyline—SLC6A4—panic disorder	0.00116	0.203	CrCbGaD
Duloxetine—SLC6A3—midbrain—panic disorder	0.00115	0.0168	CbGeAlD
Duloxetine—HTR2C—midbrain—panic disorder	0.00111	0.0162	CbGeAlD
Duloxetine—SLC6A4—midbrain—panic disorder	0.00105	0.0154	CbGeAlD
Duloxetine—HTR2A—brainstem—panic disorder	0.000871	0.0128	CbGeAlD
Duloxetine—CYP2D6—brainstem—panic disorder	0.000794	0.0116	CbGeAlD
Duloxetine—Fluoxetine—SLC6A4—panic disorder	0.000789	0.139	CrCbGaD
Duloxetine—SLC6A3—brain—panic disorder	0.00072	0.0106	CbGeAlD
Duloxetine—HTR2C—brain—panic disorder	0.000696	0.0102	CbGeAlD
Duloxetine—SLC6A4—brain—panic disorder	0.000659	0.00967	CbGeAlD
Duloxetine—Fluoxetine—HTR2A—panic disorder	0.000606	0.106	CrCbGaD
Duloxetine—SLC6A2—brain—panic disorder	0.000581	0.00851	CbGeAlD
Duloxetine—Propranolol—HTR1A—panic disorder	0.000564	0.0991	CrCbGaD
Duloxetine—HTR2A—midbrain—panic disorder	0.000555	0.00814	CbGeAlD
Duloxetine—Atomoxetine—SLC6A4—panic disorder	0.000507	0.089	CrCbGaD
Duloxetine—HTR2C—G alpha (q) signalling events—NPSR1—panic disorder	0.000428	0.00319	CbGpPWpGaD
Duloxetine—HTR2A—GPCRs, Other—ADORA2A—panic disorder	0.000426	0.00318	CbGpPWpGaD
Duloxetine—NPY1R—GPCR ligand binding—ADRA2A—panic disorder	0.000409	0.00305	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—NPSR1—panic disorder	0.000408	0.00304	CbGpPWpGaD
Duloxetine—NPY1R—GPCRs, Class A Rhodopsin-like—HTR2A—panic disorder	0.000404	0.00301	CbGpPWpGaD
Duloxetine—HTR6—GPCRs, Class A Rhodopsin-like—CCKBR—panic disorder	0.000401	0.00299	CbGpPWpGaD
Duloxetine—NPY1R—GPCR downstream signaling—CCKBR—panic disorder	0.000401	0.00298	CbGpPWpGaD
Duloxetine—SLC6A4—SIDS Susceptibility Pathways—HTR1A—panic disorder	0.000399	0.00298	CbGpPWpGaD
Duloxetine—CYP2D6—Melatonin metabolism and effects—MAOA—panic disorder	0.000398	0.00297	CbGpPWpGaD
Duloxetine—SLC6A4—Circadian rythm related genes—TPH2—panic disorder	0.000394	0.00294	CbGpPWpGaD
Duloxetine—Atomoxetine—HTR2A—panic disorder	0.000389	0.0684	CrCbGaD
Duloxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—NPSR1—panic disorder	0.000385	0.00287	CbGpPWpGaD
Duloxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—NPSR1—panic disorder	0.000383	0.00285	CbGpPWpGaD
Duloxetine—HTR6—G alpha (s) signalling events—HTR7—panic disorder	0.000382	0.00285	CbGpPWpGaD
Duloxetine—HTR2C—G alpha (q) signalling events—CCKBR—panic disorder	0.000382	0.00284	CbGpPWpGaD
Duloxetine—NPY1R—GPCR ligand binding—HTR7—panic disorder	0.000376	0.0028	CbGpPWpGaD
Duloxetine—SLC6A4—Circadian rythm related genes—ADORA2A—panic disorder	0.000376	0.0028	CbGpPWpGaD
Duloxetine—HTR2A—G alpha (q) signalling events—NPSR1—panic disorder	0.000372	0.00277	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—CCKBR—panic disorder	0.000364	0.00271	CbGpPWpGaD
Duloxetine—SLC6A2—NRF2 pathway—SLC6A4—panic disorder	0.00035	0.00261	CbGpPWpGaD
Duloxetine—HTR2A—brain—panic disorder	0.000349	0.00512	CbGeAlD
Duloxetine—NPY1R—Class A/1 (Rhodopsin-like receptors)—HTR2A—panic disorder	0.000346	0.00258	CbGpPWpGaD
Duloxetine—NPY1R—GPCR downstream signaling—RGS2—panic disorder	0.000344	0.00257	CbGpPWpGaD
Duloxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—CCKBR—panic disorder	0.000343	0.00256	CbGpPWpGaD
Duloxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—CCKBR—panic disorder	0.000341	0.00254	CbGpPWpGaD
Duloxetine—SLC6A4—Circadian rythm related genes—CRH—panic disorder	0.000339	0.00252	CbGpPWpGaD
Duloxetine—CYP1A2—Melatonin metabolism and effects—MAOA—panic disorder	0.000337	0.00251	CbGpPWpGaD
Duloxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—NPSR1—panic disorder	0.000333	0.00248	CbGpPWpGaD
Duloxetine—HTR2A—G alpha (q) signalling events—CCKBR—panic disorder	0.000332	0.00247	CbGpPWpGaD
Duloxetine—HTR2C—G alpha (q) signalling events—RGS2—panic disorder	0.000328	0.00245	CbGpPWpGaD
Duloxetine—CYP2D6—brain—panic disorder	0.000318	0.00466	CbGeAlD
Duloxetine—HTR2A—GPCRs, Other—HTR7—panic disorder	0.000313	0.00233	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—RGS2—panic disorder	0.000313	0.00233	CbGpPWpGaD
Duloxetine—NPY1R—GPCR downstream signaling—CCK—panic disorder	0.000312	0.00232	CbGpPWpGaD
Duloxetine—SLC6A3—NRF2 pathway—SLC6A4—panic disorder	0.00031	0.00231	CbGpPWpGaD
Duloxetine—HTR2C—G alpha (q) signalling events—CCK—panic disorder	0.000297	0.00221	CbGpPWpGaD
Duloxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—CCKBR—panic disorder	0.000297	0.00221	CbGpPWpGaD
Duloxetine—HTR2C—GPCRs, Class A Rhodopsin-like—CCKBR—panic disorder	0.000295	0.0022	CbGpPWpGaD
Duloxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—RGS2—panic disorder	0.000294	0.00219	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—NPSR1—panic disorder	0.000293	0.00219	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—TPH2—panic disorder	0.00029	0.00216	CbGpPWpGaD
Duloxetine—SLC6A4—SIDS Susceptibility Pathways—MAOA—panic disorder	0.00029	0.00216	CbGpPWpGaD
Duloxetine—HTR6—GPCRs, Class A Rhodopsin-like—ADORA2A—panic disorder	0.00029	0.00216	CbGpPWpGaD
Duloxetine—NPY1R—GPCR downstream signaling—ADORA2A—panic disorder	0.00029	0.00216	CbGpPWpGaD
Duloxetine—HTR2A—G alpha (q) signalling events—RGS2—panic disorder	0.000285	0.00212	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—NPSR1—panic disorder	0.000284	0.00211	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—CCK—panic disorder	0.000283	0.00211	CbGpPWpGaD
Duloxetine—SLC6A4—Circadian rythm related genes—HTR7—panic disorder	0.000276	0.00206	CbGpPWpGaD
Duloxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—CCK—panic disorder	0.000267	0.00199	CbGpPWpGaD
Duloxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—CCK—panic disorder	0.000266	0.00198	CbGpPWpGaD
Duloxetine—NPY1R—GPCR ligand binding—HTR2A—panic disorder	0.000263	0.00196	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—ADORA2A—panic disorder	0.000263	0.00196	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—CCKBR—panic disorder	0.000261	0.00195	CbGpPWpGaD
Duloxetine—NPY1R—GPCR downstream signaling—CRH—panic disorder	0.000261	0.00194	CbGpPWpGaD
Duloxetine—HTR2A—G alpha (q) signalling events—CCK—panic disorder	0.000258	0.00192	CbGpPWpGaD
Duloxetine—HTR2A—GPCRs, Class A Rhodopsin-like—CCKBR—panic disorder	0.000256	0.00191	CbGpPWpGaD
Duloxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—RGS2—panic disorder	0.000255	0.0019	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCKBR—panic disorder	0.000253	0.00188	CbGpPWpGaD
Duloxetine—HTR6—GPCRs, Class A Rhodopsin-like—HTR1A—panic disorder	0.000251	0.00187	CbGpPWpGaD
Duloxetine—NPY1R—GPCR downstream signaling—HTR1A—panic disorder	0.000251	0.00187	CbGpPWpGaD
Duloxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—ADORA2A—panic disorder	0.000248	0.00185	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—NPSR1—panic disorder	0.000246	0.00184	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—NPSR1—panic disorder	0.000241	0.0018	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—HTR1A—panic disorder	0.00024	0.00179	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—CRH—panic disorder	0.000237	0.00177	CbGpPWpGaD
Duloxetine—SLC6A4—SIDS Susceptibility Pathways—HTR2A—panic disorder	0.000237	0.00176	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—SLC6A4—panic disorder	0.000232	0.00173	CbGpPWpGaD
Duloxetine—HTR6—GPCRs, Class A Rhodopsin-like—ADRA2A—panic disorder	0.000231	0.00172	CbGpPWpGaD
Duloxetine—NPY1R—GPCR downstream signaling—ADRA2A—panic disorder	0.000231	0.00172	CbGpPWpGaD
Duloxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—CCK—panic disorder	0.000231	0.00172	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—HTR1A—panic disorder	0.000228	0.0017	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCKBR—panic disorder	0.00022	0.00164	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—NPSR1—panic disorder	0.000216	0.00161	CbGpPWpGaD
Duloxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR1A—panic disorder	0.000215	0.0016	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—CCKBR—panic disorder	0.000215	0.0016	CbGpPWpGaD
Duloxetine—HTR2C—GPCRs, Class A Rhodopsin-like—ADORA2A—panic disorder	0.000213	0.00159	CbGpPWpGaD
Duloxetine—HTR6—GPCRs, Class A Rhodopsin-like—HTR7—panic disorder	0.000213	0.00158	CbGpPWpGaD
Duloxetine—NPY1R—GPCR downstream signaling—HTR7—panic disorder	0.000213	0.00158	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—ADRA2A—panic disorder	0.00021	0.00156	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—CCK—panic disorder	0.000203	0.00151	CbGpPWpGaD
Duloxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—ADRA2A—panic disorder	0.000198	0.00148	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCK—panic disorder	0.000197	0.00147	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—HTR7—panic disorder	0.000193	0.00144	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—CCKBR—panic disorder	0.000193	0.00143	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—ADORA2A—panic disorder	0.000189	0.00141	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—NPSR1—panic disorder	0.000188	0.0014	CbGpPWpGaD
Duloxetine—HTR2A—GPCRs, Class A Rhodopsin-like—ADORA2A—panic disorder	0.000185	0.00138	CbGpPWpGaD
Duloxetine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR1A—panic disorder	0.000185	0.00138	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—RGS2—panic disorder	0.000185	0.00138	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—ADORA2A—panic disorder	0.000183	0.00136	CbGpPWpGaD
Duloxetine—SLC6A3—Transmission across Chemical Synapses—COMT—panic disorder	0.000183	0.00136	CbGpPWpGaD
Duloxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR7—panic disorder	0.000182	0.00136	CbGpPWpGaD
Duloxetine—SLC6A3—Transmission across Chemical Synapses—MAOA—panic disorder	0.000181	0.00135	CbGpPWpGaD
Duloxetine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—panic disorder	0.00018	0.00134	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—MAOA—panic disorder	0.000175	0.0013	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCK—panic disorder	0.000171	0.00127	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—CRH—panic disorder	0.00017	0.00127	CbGpPWpGaD
Duloxetine—HTR2C—GPCRs, Class A Rhodopsin-like—ADRA2A—panic disorder	0.00017	0.00127	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—CCKBR—panic disorder	0.000167	0.00125	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—CCK—panic disorder	0.000167	0.00125	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—NPSR1—panic disorder	0.000166	0.00124	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—HTR1A—panic disorder	0.000164	0.00122	CbGpPWpGaD
Duloxetine—HTR2A—GPCRs, Class A Rhodopsin-like—HTR1A—panic disorder	0.000161	0.0012	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—ADORA2A—panic disorder	0.000159	0.00118	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR1A—panic disorder	0.000159	0.00118	CbGpPWpGaD
Duloxetine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR7—panic disorder	0.000157	0.00117	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—ADORA2A—panic disorder	0.000155	0.00116	CbGpPWpGaD
Duloxetine—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—panic disorder	0.000153	0.00114	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—ADRA2A—panic disorder	0.000151	0.00112	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—NPSR1—panic disorder	0.000151	0.00112	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—CCK—panic disorder	0.00015	0.00112	CbGpPWpGaD
Duloxetine—HTR6—GPCRs, Class A Rhodopsin-like—HTR2A—panic disorder	0.000149	0.00111	CbGpPWpGaD
Duloxetine—NPY1R—GPCR downstream signaling—HTR2A—panic disorder	0.000149	0.00111	CbGpPWpGaD
Duloxetine—HTR2A—GPCRs, Class A Rhodopsin-like—ADRA2A—panic disorder	0.000148	0.0011	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—CCKBR—panic disorder	0.000148	0.0011	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—ADRA2A—panic disorder	0.000146	0.00109	CbGpPWpGaD
Duloxetine—HTR2C—G alpha (q) signalling events—HTR2A—panic disorder	0.000142	0.00106	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—CRH—panic disorder	0.00014	0.00104	CbGpPWpGaD
Duloxetine—SLC6A3—Neuronal System—COMT—panic disorder	0.00014	0.00104	CbGpPWpGaD
Duloxetine—CYP1A2—Phase II conjugation—COMT—panic disorder	0.00014	0.00104	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—ADORA2A—panic disorder	0.000139	0.00104	CbGpPWpGaD
Duloxetine—SLC6A3—Neuronal System—MAOA—panic disorder	0.000139	0.00103	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—HTR7—panic disorder	0.000139	0.00103	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—HTR1A—panic disorder	0.000138	0.00103	CbGpPWpGaD
Duloxetine—HTR2A—GPCRs, Class A Rhodopsin-like—HTR7—panic disorder	0.000136	0.00101	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—HTR2A—panic disorder	0.000135	0.00101	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—HTR1A—panic disorder	0.000135	0.001	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—CCKBR—panic disorder	0.000134	0.001	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR7—panic disorder	0.000134	0.001	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—CCK—panic disorder	0.00013	0.000969	CbGpPWpGaD
Duloxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR2A—panic disorder	0.000128	0.000951	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—RGS2—panic disorder	0.000127	0.000947	CbGpPWpGaD
Duloxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—panic disorder	0.000127	0.000946	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—ADRA2A—panic disorder	0.000127	0.000944	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—CRH—panic disorder	0.000125	0.000935	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—ADRA2A—panic disorder	0.000124	0.000923	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—NPSR1—panic disorder	0.000122	0.00091	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—ADORA2A—panic disorder	0.000121	0.000901	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—HTR1A—panic disorder	0.000121	0.0009	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—HTR7—panic disorder	0.000117	0.000868	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—RGS2—panic disorder	0.000115	0.00086	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—CCK—panic disorder	0.000115	0.000856	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—HTR7—panic disorder	0.000114	0.00085	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—ADRA2A—panic disorder	0.000111	0.000827	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—NPSR1—panic disorder	0.000111	0.000826	CbGpPWpGaD
Duloxetine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—panic disorder	0.00011	0.000817	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—CRH—panic disorder	0.000109	0.000812	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—CCKBR—panic disorder	0.000109	0.000811	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—ADORA2A—panic disorder	0.000107	0.000796	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—NPSR1—panic disorder	0.000106	0.00079	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—HTR1A—panic disorder	0.000105	0.000781	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—CCK—panic disorder	0.000104	0.000777	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—HTR7—panic disorder	0.000102	0.000761	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CCKBR—panic disorder	9.88e-05	0.000736	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—HTR2A—panic disorder	9.72e-05	0.000724	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—ADORA2A—panic disorder	9.7e-05	0.000723	CbGpPWpGaD
Duloxetine—CYP2D6—Biological oxidations—COMT—panic disorder	9.65e-05	0.000719	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—ADRA2A—panic disorder	9.64e-05	0.000719	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—CRH—panic disorder	9.63e-05	0.000717	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—NPSR1—panic disorder	9.63e-05	0.000717	CbGpPWpGaD
Duloxetine—CYP2D6—Biological oxidations—MAOA—panic disorder	9.58e-05	0.000714	CbGpPWpGaD
Duloxetine—CYP2D6—Metapathway biotransformation—COMT—panic disorder	9.52e-05	0.000709	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CCKBR—panic disorder	9.45e-05	0.000704	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—panic disorder	9.4e-05	0.0007	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—RGS2—panic disorder	9.36e-05	0.000697	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—HTR1A—panic disorder	9.27e-05	0.000691	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—NPSR1—panic disorder	8.89e-05	0.000663	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—HTR7—panic disorder	8.87e-05	0.000661	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—CRH—panic disorder	8.74e-05	0.000652	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CCKBR—panic disorder	8.58e-05	0.000639	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—ADRA2A—panic disorder	8.52e-05	0.000635	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—RGS2—panic disorder	8.5e-05	0.000633	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—CCK—panic disorder	8.46e-05	0.00063	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—HTR1A—panic disorder	8.42e-05	0.000627	CbGpPWpGaD
Duloxetine—CYP1A2—Biological oxidations—COMT—panic disorder	8.17e-05	0.000609	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—RGS2—panic disorder	8.13e-05	0.000605	CbGpPWpGaD
Duloxetine—CYP1A2—Biological oxidations—MAOA—panic disorder	8.12e-05	0.000605	CbGpPWpGaD
Duloxetine—CYP1A2—Metapathway biotransformation—COMT—panic disorder	8.06e-05	0.000601	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—HTR2A—panic disorder	7.99e-05	0.000595	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CCKBR—panic disorder	7.93e-05	0.000591	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—ADORA2A—panic disorder	7.87e-05	0.000586	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—HTR7—panic disorder	7.84e-05	0.000584	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—ADRA2A—panic disorder	7.74e-05	0.000577	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CCK—panic disorder	7.68e-05	0.000573	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—RGS2—panic disorder	7.38e-05	0.00055	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CCK—panic disorder	7.35e-05	0.000547	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—HTR2A—panic disorder	7.16e-05	0.000533	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—ADORA2A—panic disorder	7.14e-05	0.000532	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—HTR7—panic disorder	7.12e-05	0.00053	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—CRH—panic disorder	7.09e-05	0.000528	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—ADORA2A—panic disorder	6.83e-05	0.000509	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—HTR1A—panic disorder	6.83e-05	0.000509	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—RGS2—panic disorder	6.82e-05	0.000508	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CCK—panic disorder	6.67e-05	0.000497	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—NPSR1—panic disorder	6.55e-05	0.000488	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CRH—panic disorder	6.44e-05	0.00048	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—INS—panic disorder	6.34e-05	0.000473	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—ADRA2A—panic disorder	6.28e-05	0.000468	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—ADORA2A—panic disorder	6.2e-05	0.000462	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—HTR1A—panic disorder	6.2e-05	0.000462	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CCK—panic disorder	6.16e-05	0.000459	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CRH—panic disorder	6.16e-05	0.000459	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—HTR1A—panic disorder	5.93e-05	0.000442	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CCKBR—panic disorder	5.84e-05	0.000435	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—HTR7—panic disorder	5.77e-05	0.00043	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—ADORA2A—panic disorder	5.73e-05	0.000427	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—ADRA2A—panic disorder	5.7e-05	0.000425	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—NPSR1—panic disorder	5.69e-05	0.000424	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CRH—panic disorder	5.59e-05	0.000417	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—HTR2A—panic disorder	5.49e-05	0.000409	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—ADRA2A—panic disorder	5.45e-05	0.000406	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—HTR1A—panic disorder	5.38e-05	0.000401	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—HTR7—panic disorder	5.24e-05	0.000391	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CRH—panic disorder	5.17e-05	0.000385	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CCKBR—panic disorder	5.07e-05	0.000378	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—RGS2—panic disorder	5.02e-05	0.000374	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—HTR7—panic disorder	5.01e-05	0.000374	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—HTR2A—panic disorder	4.99e-05	0.000372	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—HTR1A—panic disorder	4.97e-05	0.00037	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—ADRA2A—panic disorder	4.95e-05	0.000369	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—ADRA2A—panic disorder	4.57e-05	0.000341	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—HTR7—panic disorder	4.55e-05	0.000339	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CCK—panic disorder	4.54e-05	0.000338	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—RGS2—panic disorder	4.36e-05	0.000325	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—ADORA2A—panic disorder	4.22e-05	0.000314	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—HTR7—panic disorder	4.21e-05	0.000313	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—HTR2A—panic disorder	4.04e-05	0.000301	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CCK—panic disorder	3.94e-05	0.000294	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CRH—panic disorder	3.8e-05	0.000283	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—HTR2A—panic disorder	3.67e-05	0.000274	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—ADORA2A—panic disorder	3.66e-05	0.000273	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—HTR1A—panic disorder	3.66e-05	0.000273	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—ADRA2A—panic disorder	3.37e-05	0.000251	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CRH—panic disorder	3.3e-05	0.000246	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—HTR1A—panic disorder	3.18e-05	0.000237	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—HTR7—panic disorder	3.1e-05	0.000231	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—HTR2A—panic disorder	2.95e-05	0.000219	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—ADRA2A—panic disorder	2.92e-05	0.000218	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—TPH2—panic disorder	2.72e-05	0.000203	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—HTR7—panic disorder	2.69e-05	0.0002	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—INS—panic disorder	2.34e-05	0.000174	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—TPH2—panic disorder	2.31e-05	0.000172	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—HTR2A—panic disorder	2.17e-05	0.000162	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ADRA2A—panic disorder	2.07e-05	0.000154	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ADRA2A—panic disorder	1.76e-05	0.000131	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—INS—panic disorder	1.72e-05	0.000128	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—COMT—panic disorder	1.65e-05	0.000123	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—MAOA—panic disorder	1.64e-05	0.000122	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—INS—panic disorder	1.5e-05	0.000111	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—COMT—panic disorder	1.4e-05	0.000104	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—MAOA—panic disorder	1.39e-05	0.000103	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—INS—panic disorder	1.06e-05	7.9e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—INS—panic disorder	8.99e-06	6.7e-05	CbGpPWpGaD
